News & Latest Updates

Stay informed with the latest news, scientific updates, research milestones, and company developments from Temper Bio. Explore insights into our innovative therapeutic platform, ongoing discoveries, and progress toward advancing treatments for neuroinflammatory, demyelinating, and neurodegenerative diseases.

Company News

Temper Bio advances first-in-class TAFA4 biologics platform

July 28, 2026
Temper Bio advances first-in-class TAFA4 biologics platform
Temper Bio advances first-in-class TAFA4 biologics platform
Company News

Expanding opportunities in demyelinating and neurodegenerative diseases

June 1, 2026
Expanding opportunities in demyelinating and neurodegenerative diseases
Expanding opportunities in demyelinating and neurodegenerative diseases
Arrow right Arrow left Arrow up Arrow down Arrow up right Check Check Styled Close Plus Expand Video Play Quote Star Icon info Virtual tour
Facebook Instagram Twitter Tumblr YouTube Pinterest Pinterest Soundcloud Behance Google Plus LinkedIn Search Email Tik Tok X